Northwestern Mutual Wealth Management
MDGL icon

Northwestern Mutual Wealth Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Buy
5
+2
+67% +$1.02K ﹤0.01% 3582
2026
Q1 		$1.57K Buy
+3
New +$1.43K ﹤0.01% 3662
2025
Q2 		– Sell
-3
Closed -$994 – 3865
2025
Q1 		$994 Sell
3
-1
-25% -$329 ﹤0.01% 3282
2024
Q4 		$1.23K Buy
+4
New +$1.13K ﹤0.01% 3265

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northwestern Mutual Wealth Management's MDGL Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Madrigal Pharmaceuticals (MDGL) stake by 67% in Q2 2026, buying an estimated $1.02K and bringing the position to 5 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

Northwestern Mutual Wealth Management first reported a position in MDGL in Q4 2024 and has held it in 4 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Northwestern Mutual Wealth Management held 5 shares of Madrigal Pharmaceuticals worth $2.69K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 2 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $1.02K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3582 holding.
  • Northwestern Mutual Wealth Management first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.